GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (NAS:VSTM) » Definitions » E10

Verastem (Verastem) E10 : $-16.96 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Verastem E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Verastem's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-16.96 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Verastem was 14.10% per year. The lowest was 14.10% per year. And the median was 14.10% per year.

As of today (2024-04-30), Verastem's current stock price is $9.835. Verastem's E10 for the quarter that ended in Dec. 2023 was $-16.96. Verastem's Shiller PE Ratio of today is .


Verastem E10 Historical Data

The historical data trend for Verastem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem E10 Chart

Verastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -26.74 -19.70 -18.79 -16.96

Verastem Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.79 -18.52 -18.09 -17.63 -16.96

Competitive Comparison of Verastem's E10

For the Biotechnology subindustry, Verastem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verastem's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Verastem's Shiller PE Ratio falls into.



Verastem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Verastem's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.03/129.4194*129.4194
=-1.030

Current CPI (Dec. 2023) = 129.4194.

Verastem Quarterly Data

per share eps CPI Adj_EPS
201403 -6.120 99.695 -7.945
201406 -6.120 100.560 -7.876
201409 -6.240 100.428 -8.041
201412 -6.360 99.070 -8.308
201503 -5.520 99.621 -7.171
201506 -5.040 100.684 -6.478
201509 -5.040 100.392 -6.497
201512 -3.840 99.792 -4.980
201603 -2.640 100.470 -3.401
201606 -2.760 101.688 -3.513
201609 -2.520 101.861 -3.202
201612 -3.840 101.863 -4.879
201703 -4.200 102.862 -5.284
201706 -4.320 103.349 -5.410
201709 -7.320 104.136 -9.097
201712 -5.160 104.011 -6.421
201803 -4.920 105.290 -6.048
201806 -3.600 106.317 -4.382
201809 -3.480 106.507 -4.229
201812 -4.560 105.998 -5.568
201903 -6.240 107.251 -7.530
201906 -6.840 108.070 -8.191
201909 -4.920 108.329 -5.878
201912 -6.120 108.420 -7.305
202003 -4.200 108.902 -4.991
202006 -1.680 108.767 -1.999
202009 0.960 109.815 1.131
202012 -1.440 109.897 -1.696
202103 -1.080 111.754 -1.251
202106 -1.200 114.631 -1.355
202109 -1.560 115.734 -1.744
202112 -1.080 117.630 -1.188
202203 -1.080 121.301 -1.152
202206 -1.410 125.017 -1.460
202209 -1.100 125.227 -1.137
202212 -0.970 125.222 -1.003
202303 -0.960 127.348 -0.976
202306 -1.370 128.729 -1.377
202309 -0.750 129.860 -0.747
202312 -1.030 129.419 -1.030

Add all the adjusted EPS together and divide 10 will get our e10.


Verastem  (NAS:VSTM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Verastem E10 Related Terms

Thank you for viewing the detailed overview of Verastem's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Verastem (Verastem) Business Description

Traded in Other Exchanges
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Executives
Robert E. Gagnon officer: Chief Financial Officer C/O BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON MA 02493
Daniel Calkins officer: Vice President of Finance C/O VERASTEM, INC., 117 KENDRICK STREET, SUITE 500, NEEDHAM MA 02494
Brian M Stuglik director C/O VERASTEM, INC., 117, NEEDHAM MA 02494
Dan Paterson officer: Chief Operating Officer 215 FIRST STREET, SUITE 440, CAMBRIDGE MA 02142
Karin Anna Tollefson director C/O VERASTEM, INC., 117 KENDRICK STREET, SUITE 500, NEEDHAM MA 02494
Anil Kapur director 275 MADISON AVE, SUITE 702, NEW YORK NY 10016
Bvf I Gp Llc other: See Explanation of Responses 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Gp Holdings Llc 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Ii Gp Llc other: See Explanation of Responses 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Partners Os Ltd. other: See Explanation of Responses P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Biotechnology Value Trading Fund Os Lp other: See Explanation of Responses P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Mark N Lampert 10 percent owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp other: See Explanation of Responses 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Inc/il 10 percent owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104

Verastem (Verastem) Headlines

From GuruFocus

Verastem Oncology Announces Reverse Stock Split

By Business Wire Business Wire 05-31-2023